Cholesterol study ranks effectiveness of statins

Gough, Rob
November 2002
Pulse;11/11/2002, Vol. 62 Issue 43, p7
Examines the use of statins for first-line treatment of coronary heart disease (CHD) in Great Britain. Efficacy of statins in reducing cholesterol in the body; Mechanism of action of each agent; Benefits of the treatment for CHD patients.


Related Articles

  • Patients with acute coronary syndrome should start a statin while still in hospital. Isles, C.G. // Heart;Jul2002, Vol. 88 Issue 1, p5 

    Editorial. Focuses on the use of statins for the treatment of coronary heart disease in Great Britain. Clinical profile of patients with coronary heart disease; Barriers to prescribing prophylactic drugs following myocardial infarction; Beneficial effects of statins.

  • Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Reid, F.D.A.; Cook, D.G.; Whincup, P.H. // Heart;Jul2002, Vol. 88 Issue 1, p15 

    Objective: To investigate possible inequities in the use of statins for people with coronary heart disease according to a wide range of social and clinical factors. Design and setting: Cross sectional analysis of data from the Health Survey for England 1998, a population based survey. Subjects:...

  • Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo. Nieminen, M S; Viikari, J; Ahotupa, M; Vasankari, T; Kantola, I; Strandberg, T; Vanhanen, H // Journal of Human Hypertension;Aug2001 Supplement, Vol. 15 Issue 8, pS27 

    Discusses effects of atorvastatins on the prevention of coronary heart disease complications. Reasons provided for occurrence of the heart diseases in patients despite statin treatment; Effect of atorvastatin on atherogenic lipid profile; Impact of statins on low-density lipoprotein composition.

  • Managing hyperlipidemia: Current and future roles of HMG-CoA reductase inhibitors. Lopez, Larry M. // American Journal of Health-System Pharmacy;6/15/2002, Vol. 59 Issue 12, p1173 

    Discusses the roles of statins as antilipemic agents for the prevention and management of coronary artery disease. Therapy with hydroxymethylglutaryl-coenzyme A reductase inhibitors; Reduction in total and low-density-lipoprotein cholesterol concentrations; Comparative efficacy of statins;...

  • First solid evidence that lipid-lowering drugs improve CHD survival.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p18 

    Reveals that long-term lipid-lowering therapy with an HMG CoA reductase inhibitor significantly reduces total mortality in patients who have coronary heart disease in Norway based on a study by Dr. Terje Pedersen. Results of previous trial of any antihyperlipidemic therapy; Kinds of `statin'...

  • Does Atorvastatin Have Anti-ischemic Effects? Boyle, Andrew J. // Internal Medicine Alert;1/29/2011, Vol. 33 Issue 2, p11 

    The article examines the anti-ischemic benefits for ischemia of atorvastatin, a drug for coronary artery disease (CAD) treatment.

  • Rosuvastatin no better than atorvastatin. Elliott, William T. // Travel Medicine Advisor;Nov2011 Supplement, p1 

    The article informs of a study which compares the effectiveness of rosuvastanin, a drug class of statins, with another drug class of statins, atorvastanin, and states that the effectiveness of rosuvastanin is no better than atorvastanin in treating coronary atheroma, a coronary artery disease.

  • Talking point.  // Pulse;Aug2013, p15 

    The article presents questions and answers related to the study which investigates the benefits and safety of statins in treating coronary heart disease (CHD), conducted by the West Scotland Coronary Prevention Study (WOSCOPS.)

  • NZ, British, Australian statin guidelines best bet.  // PharmacoEconomics & Outcomes News;6/17/2006, Issue 505, p1 

    The article discusses research being done on the effectiveness and efficiency of different guidelines on statin treatment for preventing mortality from coronary heart disease (CHD). It references a study by D. G. Manuel and colleagues in the June 1, 2006 online issue of the "British Medical...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics